Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicinesDesignation granted for warm autoimmune hemolytic anemia and IgG4-related…Read More

You might also be interested in reading Peter Thiel-backed crypto exchange Bullish files for US IPO: FT.